AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
    • Publication Information:
      Original Publication: New York, NY : Nature Pub. Co., c1992-
    • Subject Terms:
    • Abstract:
      Degeneration of photoreceptors is a common feature of ciliopathies, owing to the importance of the specialized ciliary structure of these cells. Mutations in AHI1, which encodes a cilium-localized protein, have been shown to cause a form of Joubert syndrome that is highly penetrant for retinal degeneration. We show that Ahi1-null mice fail to form retinal outer segments and have abnormal distribution of opsin throughout their photoreceptors. Apoptotic cell death of photoreceptors occurs rapidly between 2 and 4 weeks of age in these mice and is significantly (P = 0.00175 and 0.00613) delayed by a reduced dosage of opsin. This phenotype also shows dosage-sensitive genetic interactions with Nphp1, another ciliopathy-related gene. Although it is not a primary cause of retinal blindness in humans, we show that an allele of AHI1 is associated with a more than sevenfold increase in relative risk of retinal degeneration within a cohort of individuals with the hereditary kidney disease nephronophthisis. Our data support context-specific roles for AHI1 as a contributor to retinopathy and show that AHI1 may explain a proportion of the variability in retinal phenotypes observed in nephronophthisis.
    • References:
      Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2413-21. (PMID: 12766038)
      Eur J Med Genet. 2008 Jan-Feb;51(1):24-34. (PMID: 18054307)
      Hum Mol Genet. 2001 Mar 15;10(6):591-7. (PMID: 11230178)
      Hum Mol Genet. 2009 May 1;18(9):1566-77. (PMID: 19208653)
      Traffic. 2009 Jun;10(6):648-63. (PMID: 19302411)
      Kidney Int. 2006 Oct;70(7):1342-7. (PMID: 16900087)
      Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):16-22. (PMID: 14603031)
      J Cell Biol. 2002 Apr 1;157(1):103-13. (PMID: 11916979)
      Vision Res. 2006 Dec;46(27):4427-33. (PMID: 17010408)
      Prog Retin Eye Res. 2008 Jul;27(4):391-419. (PMID: 18632300)
      Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):736-41. (PMID: 9892703)
      Vision Res. 2006 Dec;46(27):4510-8. (PMID: 16979686)
      Curr Biol. 2007 Sep 18;17(18):1586-94. (PMID: 17825558)
      Am J Kidney Dis. 1998 Dec;32(6):1059-62. (PMID: 9856524)
      Cell. 2001 Apr 6;105(1):43-55. (PMID: 11301001)
      Kidney Int. 2008 Nov;74(9):1139-49. (PMID: 18633336)
      Nat Genet. 2009 Jun;41(6):739-45. (PMID: 19430481)
      Invest Ophthalmol Vis Sci. 2002 Jan;43(1):22-32. (PMID: 11773008)
      Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8840-4. (PMID: 1924344)
      Am J Hum Genet. 1993 Mar;52(3):506-16. (PMID: 8447318)
      J Am Soc Nephrol. 2007 May;18(5):1566-75. (PMID: 17409309)
      Neuron. 2005 Nov 3;48(3):387-401. (PMID: 16269358)
      Nat Med. 2009 Sep;15(9):1046-54. (PMID: 19718039)
      J Biol Chem. 2004 Nov 12;279(46):48189-96. (PMID: 15337746)
      Nat Genet. 1997 Feb;15(2):216-9. (PMID: 9020854)
      J Virol. 2002 Sep;76(18):9046-59. (PMID: 12186888)
      Transgenic Res. 2004 Apr;13(2):155-64. (PMID: 15198203)
      Exp Cell Res. 1998 Jul 10;242(1):10-7. (PMID: 9665797)
      Nat Genet. 1997 Oct;17(2):149-53. (PMID: 9326933)
      J Med Genet. 2006 Apr;43(4):334-9. (PMID: 16155189)
      Cell. 2000 Jul 21;102(2):175-87. (PMID: 10943838)
      Nat Genet. 2004 Sep;36(9):1008-13. (PMID: 15322546)
      Nat Genet. 1999 Sep;23(1):99-103. (PMID: 10471508)
      Hum Mol Genet. 2009 Oct 15;18(20):3926-41. (PMID: 19625297)
      BMC Bioinformatics. 2006 Mar 22;7:166. (PMID: 16551372)
      Hum Mol Genet. 1996 Mar;5(3):367-71. (PMID: 8852662)
      Neuron. 2006 Jan 5;49(1):55-66. (PMID: 16387639)
      Ann Neurol. 2006 Mar;59(3):527-34. (PMID: 16453322)
      Nature. 1987 Mar 19-25;326(6110):292-5. (PMID: 3821905)
      J Am Soc Nephrol. 2006 Sep;17(9):2424-33. (PMID: 16885411)
      Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):1027-32. (PMID: 17209010)
      J Ocul Pharmacol Ther. 2004 Jun;20(3):217-36. (PMID: 15279727)
      Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5860-5. (PMID: 8650183)
      Am J Hum Genet. 2004 Dec;75(6):979-87. (PMID: 15467982)
      Curr Top Dev Biol. 2008;84:249-310. (PMID: 19186246)
    • Grant Information:
      R01 EY013408-05A2 United States EY NEI NIH HHS; F31NS059281 United States NS NINDS NIH HHS; P30NS047101 United States NS NINDS NIH HHS; R01EY007042 United States EY NEI NIH HHS; R01DK068306 United States DK NIDDK NIH HHS; R01 EY007042 United States EY NEI NIH HHS; R01 NS048453 United States NS NINDS NIH HHS; R01 DK068306 United States DK NIDDK NIH HHS; GGP08145 Italy TI_ Telethon; T32 GM008666 United States GM NIGMS NIH HHS; F31 NS059281 United States NS NINDS NIH HHS; R01 EY013408 United States EY NEI NIH HHS; R01NS048453 United States NS NINDS NIH HHS; P30 NS047101 United States NS NINDS NIH HHS
    • Accession Number:
      0 (Adaptor Proteins, Signal Transducing)
      0 (Adaptor Proteins, Vesicular Transport)
      0 (Ahi1 protein, mouse)
      0 (Carrier Proteins)
      0 (Cytoskeletal Proteins)
      0 (Nphp1 protein, mouse)
      0 (Opsins)
      0 (Proto-Oncogene Proteins)
    • Publication Date:
      Date Created: 20100119 Date Completed: 20100217 Latest Revision: 20211020
    • Publication Date:
      20240104
    • Accession Number:
      PMC2884967
    • Accession Number:
      10.1038/ng.519
    • Accession Number:
      20081859